NeRRe Therapeutics
Andrew has extensive board and business experience both in Biotech and major pharmaceutical companies. Currently Chairman Nucana Plc, Chairman Blueberry Therapeutics, Consultant & Advisor to Boards and Executive teams in Biotech and Healthcare companies. Director of Amulet Consulting specialising in advisory roles with biotech.
This person is not in the org chart
This person is not in any teams
NeRRe Therapeutics
NeRRe Therapeutics is a biotechnology company that develops clinical and pre-clinical neurokinin receptor antagonists.